Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
37 /100
MEDIUM RISK
Score updated Aug 28, 2026

DMAC — DiaMedica Therapeutics Inc. Dilution Risk Tracker

Track DMAC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DMAC — Get alerts when the score changes →

As of August 28, 2026, DiaMedica Therapeutics Inc. (DMAC) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. DiaMedica Therapeutics Inc. has a market capitalization of $322.76M, 53.93M shares outstanding, 98 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
25
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for DMAC.
🔔 Track DMAC — Get forecast alerts →

Market Data

Market Cap$322.76M
Shares Outstanding53.93M
Float28.60M
Cash$43.50M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 9.3% shares (2026Q1 vs prior)
98 institutional holders · 13.52M shares
#1 COOPERMAN LEON G 2.02M shares
#2 BlackRock, Inc. 1.86M shares
#3 MORGAN STANLEY 1.23M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.20M
Days to Cover27.4
% of Float18.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news
Track DMAC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DMAC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DMAC
DMAC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.